The Goldman Sachs Group Begins Coverage on Tarsus Pharmaceuticals (NASDAQ:TARS)

The Goldman Sachs Group initiated coverage on shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $19.00 price target on the stock. Other equities research analysts have also issued research reports about the stock. HC Wainwright upped their […]

Leave a Reply

Your email address will not be published.

Previous post Chicago Bears and quarterback Justin Fields look to better handle Minnesota Vikings pressure in rematch
Next post Equifax (NYSE:EFX) Research Coverage Started at Citigroup